These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3614989)

  • 21. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
    Coelho AC; Oliveira JC; Espada CR; Reimão JQ; Trinconi CT; Uliana SR
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004660. PubMed ID: 27144739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.
    Giudice A; Camada I; Leopoldo PT; Pereira JM; Riley LW; Wilson ME; Ho JL; de Jesus AR; Carvalho EM; Almeida RP
    BMC Infect Dis; 2007 Feb; 7():7. PubMed ID: 17316450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
    Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
    Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a juvenile hormone analogue on Leishmania amazonensis and Leishmania braziliensis.
    Esteva M; Maidana C; Sinagra A; Luna C; Ruiz AM; Stoka AM
    Exp Parasitol; 2005 Jun; 110(2):162-4. PubMed ID: 15888299
    [No Abstract]   [Full Text] [Related]  

  • 26. Golden hamster (Mesocricetus auratus) as an experimental model for Leishmania (Viannia) braziliensis infection.
    Gomes-Silva A; Valverde JG; Ribeiro-Romão RP; Plácido-Pereira RM; Da-Cruz AM
    Parasitology; 2013 May; 140(6):771-9. PubMed ID: 23369503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.
    Navin TR; Arana BA; Arana FE; Berman JD; Chajón JF
    J Infect Dis; 1992 Mar; 165(3):528-34. PubMed ID: 1311351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis.
    de Mello TF; Bitencourt HR; Pedroso RB; Aristides SM; Lonardoni MV; Silveira TG
    Exp Parasitol; 2014 Jan; 136():27-34. PubMed ID: 24269198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antileishmanial activity of human red blood cells containing formycin A.
    Berman JD; Gallalee JV
    J Infect Dis; 1985 Apr; 151(4):698-703. PubMed ID: 3973416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological studies on American leishmaniasis in Ceará State, Brazil. Molecular characterization of the Leishmania isolates.
    Vasconcelos IA; Vasconcelos AW; Momen H; Grimaldi G; Alencar JE
    Ann Trop Med Parasitol; 1988 Dec; 82(6):547-54. PubMed ID: 3256276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of formycin B on mRNA translation and uptake of purine precursors in Leishmania mexicana.
    Nolan LL; Berman JD; Giri L
    Biochem Int; 1984 Aug; 9(2):207-18. PubMed ID: 6207832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
    Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
    J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental chemotherapy in hamsters, using paromomycin against 2 isolates of Leishmania mexicana and Leishmania braziliensis].
    Rezzano S; Moreno G; Scorza JV
    Rev Cubana Med Trop; 1982; 34(1):34-45. PubMed ID: 6750713
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular typing reveals the co-existence of two transmission cycles of American cutaneous leishmaniasis in the Andean Region of Venezuela with Lutzomyia migonei as the vector.
    Torrellas A; Ferrer E; Cruz I; Lima H; Delgado O; Rangel JC; Bravo JA; Chicharro C; Llanes-Acevedo IP; Miles MA; Feliciangeli MD
    Mem Inst Oswaldo Cruz; 2018 Dec; 113(12):e180323. PubMed ID: 30540021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leishmaniasis in the major endemic region of Plurinational State of Bolivia: Species identification, phylogeography and drug susceptibility implications.
    Bilbao-Ramos P; Dea-Ayuela MA; Cardenas-Alegría O; Salamanca E; Santalla-Vargas JA; Benito C; Flores N; Bolás-Fernández F
    Acta Trop; 2017 Dec; 176():150-161. PubMed ID: 28751163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy.
    Avila JL; Biondo F; Monzón H; Convit J
    Am J Trop Med Hyg; 1982 Jan; 31(1):53-9. PubMed ID: 7058978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental models of cutaneous leishmaniasis in laboratory animals].
    Pleskanovskaia SA
    Parazitologiia; 1986; 20(2):120-5. PubMed ID: 3714297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis.
    Morais-Teixeira Ed; Carvalho AS; Costa JC; Duarte SL; Mendonça JS; Boechat N; Rabello A
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):358-62. PubMed ID: 18660990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.